Evidence map›Paper›PMID 38661084›Full record

Trial reportThe Journal of clinical endocrinology and metabolism2025

Long-term Cumulative Incidence of Clinically Diagnosed Retinopathy in the Finnish Diabetes Prevention Study.

Kai Kaarniranta, Mikko Valtanen, Sirkka Keinänen-Kiukaanniemi, Jaakko Tuomilehto, Jaana Lindström, Matti Uusitupa

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The Journal of clinical endocrinology and metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Kai KaarnirantaInstitute of Medical Sciences, School of Medicine, University of Eastern Finland, 70211 Kuopio, Finland.ORCID 0000-0003-2600-8679
Mikko ValtanenDepartment of Chronic Disease Prevention, National Institute for Health and Welfare, 00271 Helsinki, Finland.
Sirkka Keinänen-KiukaanniemiCenter for Life Course Health Research, University of Oulu, 90014 Oulu, Finland.
Jaakko TuomilehtoDepartment of Chronic Disease Prevention, National Institute for Health and Welfare, 00271 Helsinki, Finland.
Jaana LindströmDepartment of Chronic Disease Prevention, National Institute for Health and Welfare, 00271 Helsinki, Finland.ORCID 0000-0001-9255-020X
Matti UusitupaSchool of Medicine, Institute of Public Health and Clinical Nutrition, University of Eastern Finland, 70211 Kuopio, Finland.
Finnish Institute for Health and Welfare · FIUniversity of Eastern Finland · FIOulu University of Applied Sciences · FIUniversity of Helsinki · FI

Funding

Academy of FinlandFinnish Eye FoundationSigrid Juselius Foundation
6 · The paper itself

Abstract

contextLifestyle intervention reduces the incidence of type 2 diabetes (T2D) in people with impaired glucose tolerance (IGT).

objectiveThis work aimed to find out whether participation in an earlier lifestyle intervention had an effect on the occurrence of clinically diagnosed diabetic retinopathy (DR) during a median of 22 years of follow-up time.

methodsThe study included 505 individuals from the Finnish Diabetes Prevention Study (DPS) (mean age 55; range, 40-64 years at the onset of the study) with IGT who were originally randomly assigned to the intervention (weight loss, healthy diet, and physical activity) (N = 257) and usual care control groups (N = 248). The median follow-up was 22 years. Clinical retinopathy diagnoses were obtained from the Finnish national hospital Care Register for Health. Data on glycemic parameters, serum lipids, and blood pressure were available from both the intervention (median 4 years) and postintervention period (until year 7).

resultsNo significant difference was found in the cumulative incidence of clinically diagnosed DR between the original intervention (N = 23, 8.9%) and control groups (N = 19, 7.7%) during the extended follow-up (odds ratio: 1.15; 95% CI, 0.61-2.21). A higher cumulative glycated hemoglobin A1c (HbA1c) was significantly associated with a higher risk of retinopathy (hazard ratio 1.4; 1.02-1.88, 95% posterior interval, adjusted for group, age, and sex). Furthermore, the incidence of retinopathy diagnosis was numerically more common among individuals who had developed diabetes during the follow-up (33/349) compared with those who had not (9/156); however, the comparison was not statistically significant (odds ratio: 1.86, 95% CI, 0.89-4.28, adjusted for group, age, and sex).

conclusionA higher cumulative HbA1c was significantly associated with a higher risk of retinopathy. No evidence was found for a beneficial effect of a 4-year lifestyle intervention on the long-term occurrence of clinical DR during a median of 22-year follow-up.

Indexed as

Diabetes Mellitus, Type 2Diabetic RetinopathyAdultDiet, HealthyExerciseFemaleFinlandFollow-Up StudiesGlucose IntoleranceGlycated HemoglobinHumansIncidenceLife StyleMaleMiddle AgedRisk FactorsGlycated HemoglobindiabetesglucoseHbA1clifestyle interventionpreventionretinopathy

Identifiers

PMID38661084
PMCPMC11834719
OpenAlexW4395118051

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.